Posted by Michael Wonder on 04 Mar 2019
Lilly to introduce lower-priced insulin
4 March 2019 - Authorised generic version of Humalog will be available in U.S. pharmacies at 50 percent lower list price.
Reinforcing our commitment to lower out-of-pocket costs for people who need insulin, Eli Lilly today announced we will introduce a lower-priced version of Humalog (insulin lispro injection 100 units/mL) in the United States -- providing people with diabetes an insulin option that will have a list price 50 percent lower than the current Humalog list price.
The lower-priced version will be called Insulin Lispro—the same molecule as Humalog—and will be available in vial and pen options. The list price of a single vial will be $137.35. The list price of a five-pack of KwikPens will be $265.20. Vials and pens of the lower-priced insulin have been manufactured, and Lilly will now work with supply chain partners to make them available in pharmacies as quickly as possible.
